跳转至内容
Merck
CN

SML3558

CQ211

≥98% (HPLC)

别名:

1,5-Dihydro-8-(6-methoxy-3-pyridinyl)-1-[4-(1-piperazinyl)-3-(trifluoromethyl)phenyl]- 4H -1,2,3-triazolo[4,5-c ]quinolin-4-one, 8‑(6-Methoxypyridin-3-yl)-1-(4-(piperazin-1-yl)-3-(trifluoromethyl)phenyl)-1,5-dihydro-4H-[1,2,3]triazolo[4,5‑c]quinolin-4-one

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C26H22F3N7O2
化学文摘社编号:
分子量:
521.49
UNSPSC Code:
12352200
NACRES:
NA.21
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

Quality Level

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

O=C1C2=C(C3=CC(C4=CC=C(N=C4)OC)=CC=C3N1)N(N=N2)C5=CC=C(C(C(F)(F)F)=C5)N6CCNCC6

Biochem/physiol Actions

CQ211 is a cell penetrant, selective and highly potent RIOK2 (Right open reading frame kinase 2) inhibitor. CQ211 potently inhibits proliferation of multiple cancer cell lines including MKN-1 and HT-29 cells. It inhibits tumor progression in MKN-1 xenograft model after intraperitoneal administration.
Cell penetrant, selective and highly potent RIOK2 (Right open reading frame kinase 2) inhibitor

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品

此项目有


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Yifan Ouyang et al.
Journal of medicinal chemistry, 65(11), 7833-7842 (2022-05-19)
RIOK2 is an atypical kinase implicated in multiple human cancers. Although recent studies establish the role of RIOK2 in ribosome maturation and cell cycle progression, its biological functions remain poorly elucidated, hindering the potential to explore RIOK2 as a therapeutic

全球贸易项目编号

货号GTIN
SML3558-5MG04065268079003
SML3558-25MG04065268078990

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持